Immune Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Immune Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-01-10Clinical Trial Update: Cerebral Dysfunction in Chronic ITPwith High Risk of Serious Bleeding Excluding Intracranial Hemorrhage.
This document provides an update on a clinical trial evaluating cerebral dysfunction risk in patients with chronic immune thrombocytopenia w…
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Oxidant Status and Effect of Antioxidant in Immune Thrombocytopenia [Phase 2, Phase 3]
An update on a Phase 2/Phase 3 clinical trial evaluating the effect of an antioxidant on oxidant status in immune thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2012-11-15Clinical Trial Update: Efficacy and Safety of Rituximab Given at Fixed Dose (1000 mg on Days 1 and 15) Compared to the Standard Regimen in Adult's Immune Thrombocytopenia
This completed trial compared a fixed-dose rituximab schedule (1000 mg on days 1 and 15) with the standard regimen in adults with primary im…
-
FDA approval · 2012-11-02FDA Approved: NPLATE — Supplemental Application (Amgen, Inc)
FDA approved a supplemental application for NPLATE (romiplostim) from Amgen, approving an update to the product's labeling and/or indication…
-
CLINICAL_TRIALS trial_result · 2012-10-25Clinical Trial Update: Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura [NA]
This completed clinical trial update examines vaccine response following rituximab treatment in patients with chronic, severe immune thrombo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-10-23Clinical Trial Update: Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune Thrombocytopenia
This update reports the efficacy results of a completed trial evaluating all-trans retinoic acid as an immunomodulatory therapy for adults w…
-
CLINICAL_TRIALS research · 2012-10-23Clinical Trial Update: The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders
An observational ClinicalTrials.gov update (RITAI Cohort) investigates off-label use of rituximab for autoimmune disorders, including pemphi…
-
CLINICAL_TRIALS trial_result · 2012-08-24Clinical Trial Update: Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia
This document reports on a completed clinical trial evaluating the efficacy of rapamycin therapy in patients with chronic immune thrombocyto…
-
CLINICAL_TRIALS trial_result · 2012-06-13Clinical Trial Update: Eltrombopag and Romiplostim Used Alternatively in Patients With Immune Thrombopenia (ITP): Efficacy and Safety.
This completed clinical trial compared alternating use of eltrombopag and romiplostim in immune thrombocytopenia and reported on efficacy an…
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP) [Phase 2]
This document reports the completion of a Phase 2 pilot trial evaluating Rituximab for the treatment of acute immune thrombocytopenic purpur…
-
CLINICAL_TRIALS research · 2012-03-21Clinical Trial Update: Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune Thrombocytopenia
A retrospective analysis assessing the safety and efficacy of hydroxychloroquine in immune thrombocytopenia, including cases with systemic l…
-
CLINICAL_TRIALS research · 2012-03-21Clinical Trial Update: The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.
A clinical trial update for the ITP-RITUX cohort examining rituximab in immune thrombocytopenia, sponsored by Henri Mondor University Hospit…
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: Subject Variability in Two Lots of E5501 Administered to Fed and Fasted Healthy Subjects [Phase 1]
Phase 1 pharmacokinetic variability study evaluating two lots of E5501 administered to fed and fasted healthy subjects.
-
FDA approval · 2011-12-06FDA Approved: NPLATE — Supplemental Application (Amgen, Inc)
The FDA approved Amgen's supplemental application for NPLATE (romiplostim), resulting in updated labeling.
-
CLINICAL_TRIALS trial_result · 2011-11-23Clinical Trial Update: Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10 [Phase 3]
A Phase 3 trial evaluating Intravenous Immunoglobulin IgPro10 for immune thrombocytopenia has completed, with results posted in 2011.
-
FDA approval · 2011-06-21FDA Approved: NPLATE — Supplemental Application (Amgen, Inc)
The FDA approved a supplemental application for NPLATE (romiplostim) from Amgen.
-
CLINICAL_TRIALS trial_result · 2011-04-06Clinical Trial Update: Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) [Phase 3]
Open-label extension of romiplostim in patients with immune thrombocytopenia (Idiopathic Thrombocytopenic Purpura) in a Phase 3 study; the t…
-
CLINICAL_TRIALS trial_result · 2011-03-01Clinical Trial Update: Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects [Phase 1, Phase 2]
Phase 1/2 study evaluating safety and efficacy of romiplostim in pediatric idiopathic thrombocytopenic purpura completed; results posted in …
-
CLINICAL_TRIALS trial_result · 2010-07-15Clinical Trial Update: Efficacy of Helicobacter Pylori Eradication, Anti-D and Danazol Combination in Steroid Dependant or Refractory Immune Thrombocytopenia (ITP) [Phase 2]
Phase 2 trial evaluating a combination of Helicobacter pylori eradication, Anti-D immunoglobulin, and danazol for steroid-dependent or refra…
-
FDA approval · 2010-03-23FDA Approved: NPLATE — Supplemental Application (Amgen, Inc)
FDA approved a supplemental application for NPLATE (romiplostim) submitted by Amgen, Inc.
-
CLINICAL_TRIALS trial_result · 2010-02-23Clinical Trial Update: RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag [Phase 3]
Phase 3 randomized, placebo-controlled trial of eltrombopag in idiopathic immune thrombocytopenia completed. Results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2009-12-31Clinical Trial Update: Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP) [Phase 3]
This is a Phase 3 clinical evaluation of SB-497115-GR for chronic immune thrombocytopenia. The trial has completed and its results were post…
-
CLINICAL_TRIALS trial_result · 2009-11-17Clinical Trial Update: Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the " Real-life " : Result of the French Experience in 72 Adults
This clinical trial update evaluates the real-world safety and efficacy of romiplostim in adults with immune thrombocytopenia in France. Dat…
-
FDA approval · 2009-09-18FDA Approved: NPLATE — Supplemental Application (Amgen, Inc)
The FDA approved a supplemental application for NPLATE (romiplostim) from Amgen, Inc.
-
FDA approval · 2009-08-14FDA Approved: NPLATE — Supplemental Application (Amgen, Inc)
The FDA approved a supplemental application for NPLATE (romiplostim) submitted by Amgen, Inc. The notice does not specify new indications or…